The efficacy of anakinra compared to standard care of treatment for COVID-19: a meta-analysis

BACKGROUND/AIM: As SARS-CoV-2 continues to spread worldwide, this study brings to light the link that anakinra, a recombinant IL-1 receptor antagonist, has in averting grave clinical outcomes. The objectives of this meta-analysis are to investigate the effects of anakinra in interventional groups co...

Descripción completa

Detalles Bibliográficos
Autores principales: MALIK, Hamna, BINT ABDUL JABBAR, Hira, LATIF, Farah, SARFRAZ, Azza, SARFRAZ, Zouina, SARFRAZ, Muzna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390186/
https://www.ncbi.nlm.nih.gov/pubmed/36326309
http://dx.doi.org/10.55730/1300-0144.5345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390186/
https://www.ncbi.nlm.nih.gov/pubmed/36326309
http://dx.doi.org/10.55730/1300-0144.5345

Ejemplares similares